• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国锥虫病(恰加斯病)。

American Trypanosomiasis (Chagas Disease).

机构信息

Grupo de Estudios Epidemiológicos y Salud Pública, Heart Failure and Heart Transplant Clinic, Fundacion Cardiovascular de Colombia, Calle 155 A No. 23-58, Urbanizacion El Bosque, Floridablanca, Santander, Colombia.

Division of Cardiology, Department of Cardiac Sciences, Libin Cardiovascular Institute of Alberta, University of Calgary, Foothills Medical Centre, Room C823, 1403 29th Street Northwest, Calgary, Alberta T2N 2T9, Canada.

出版信息

Infect Dis Clin North Am. 2019 Mar;33(1):119-134. doi: 10.1016/j.idc.2018.10.015.

DOI:10.1016/j.idc.2018.10.015
PMID:30712757
Abstract

American trypanosomiasis is caused by a parasite endemic of the Americas. Current migration has globalized Chagas disease. Acute infection usually resolves spontaneously. Nonetheless, 20% to 40% develop cardiomyopathy 20 to 30 years later. Progression to cardiomyopathy is devastatingly rapid, manifesting with heart failure and sudden death. Etiologic treatment is highly effective and recommended in those with acute infections, congenital infections, and parasite reactivation, and women of childbearing age, but in asymptomatic Trypanosoma cruzi carriers and patients with early cardiomyopathy remains controversial and under investigation. Progression of heart failure is rapid and accounts for most of the morbidity and related mortality.

摘要

美洲锥虫病由美洲特有的寄生虫引起。目前的移民潮使恰加斯病全球化。急性感染通常会自行消退。然而,20%到 40%的人在 20 到 30 年后会发展为心肌病。进展为心肌病的速度非常快,表现为心力衰竭和猝死。病因治疗在急性感染、先天性感染和寄生虫再激活以及育龄妇女中非常有效且推荐,但在无症状的克氏锥虫携带者和早期心肌病患者中仍存在争议,且正在研究中。心力衰竭的进展迅速,是导致大多数发病率和相关死亡率的主要原因。

相似文献

1
American Trypanosomiasis (Chagas Disease).美国锥虫病(恰加斯病)。
Infect Dis Clin North Am. 2019 Mar;33(1):119-134. doi: 10.1016/j.idc.2018.10.015.
2
Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial.慢性恰加斯心肌病:基于苯硝唑治疗锥虫病疗效评估(BENEFIT)试验对主要致病机制及病因治疗效果的综述
Mem Inst Oswaldo Cruz. 2017 Mar;112(3):224-235. doi: 10.1590/0074-02760160334. Epub 2017 Feb 16.
3
Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.在实验性恰加斯病的慢性期用苄硝唑治疗可减少心脏病变。
Antimicrob Agents Chemother. 2005 Apr;49(4):1521-8. doi: 10.1128/AAC.49.4.1521-1528.2005.
4
Perspectives in Chagas disease treatment.恰加斯病治疗的展望。
Glob Heart. 2015 Sep;10(3):189-92. doi: 10.1016/j.gheart.2015.07.007.
5
Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection).用于晚期有症状的恰加斯病(克氏锥虫感染)的杀锥虫药物。
Cochrane Database Syst Rev. 2005 Oct 19(4):CD004102. doi: 10.1002/14651858.CD004102.pub2.
6
Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy.随机试验用苯硝唑治疗慢性恰加斯心肌病。
N Engl J Med. 2015 Oct;373(14):1295-306. doi: 10.1056/NEJMoa1507574. Epub 2015 Sep 1.
7
Pediatric clinical pharmacology studies in Chagas disease: focus on Argentina.恰加斯病的儿科临床药理学研究:聚焦阿根廷
Paediatr Drugs. 2009;11(1):33-7. doi: 10.2165/0148581-200911010-00012.
8
Antitrypanosomal therapy for chronic Chagas' disease.慢性恰加斯病的抗锥虫治疗。
N Engl J Med. 2011 Jun 30;364(26):2527-34. doi: 10.1056/NEJMct1014204.
9
Acute chagasic myocardiopathy after orthotopic liver transplantation with donor and recipient serologically negative for Trypanosoma cruzi: a case report.原位肝移植后供体和受体血清学检测克氏锥虫均为阴性的急性恰加斯心肌病:一例报告
Transplant Proc. 2008 Apr;40(3):875-8. doi: 10.1016/j.transproceed.2008.02.032.
10
Chagas disease. American trypanosomiasis.恰加斯病。美洲锥虫病。
Infect Dis Clin North Am. 1993 Sep;7(3):487-502.

引用本文的文献

1
In Silico Investigation of TATA-Binding Protein as a Therapeutic Target for Chagas Disease: Insights into FDA Drug Repositioning.计算机模拟研究TATA结合蛋白作为恰加斯病的治疗靶点:对美国食品药品监督管理局药物重新定位的见解
Pharmaceuticals (Basel). 2025 Jun 4;18(6):845. doi: 10.3390/ph18060845.
2
Epidemiology and Short-Term Outcomes of Heart Failure With Preserved and Mildly Reduced Ejection Fraction in Colombia: Insights of the Colombian Heart Failure Registry (RECOLFACA).哥伦比亚射血分数保留及轻度降低的心衰的流行病学和短期结局:哥伦比亚心力衰竭登记研究(RECOLFACA)的见解
Cardiol Res. 2025 Jun;16(3):267-277. doi: 10.14740/cr2015. Epub 2025 May 7.
3
Short versus long drug regimens for Chagas disease.
治疗恰加斯病的短疗程与长疗程药物方案
Cochrane Database Syst Rev. 2025 May 9;5(5):CD016172. doi: 10.1002/14651858.CD016172.
4
Coinfection by multiple clones: a new perspective on host-parasite relationship with consequences for pathogenesis and management of Chagas disease.多种克隆的共感染:宿主 - 寄生虫关系的新视角及其对恰加斯病发病机制和管理的影响
Microbiol Mol Biol Rev. 2025 Jun 25;89(2):e0024224. doi: 10.1128/mmbr.00242-24. Epub 2025 Mar 21.
5
Pharmacokinetics of two pharmaceutical presentations of benznidazole in adult Trypanosoma cruzi infected population.两种苯硝唑制剂在成年克氏锥虫感染人群中的药代动力学
Mem Inst Oswaldo Cruz. 2025 Feb 28;120:e240177. doi: 10.1590/0074-02760240177. eCollection 2025.
6
Structure-Based Identification of Non-covalent Prolyl Oligopeptidase 80 Inhibitors Targeting Cell Entry.基于结构的靶向细胞进入的非共价脯氨酰寡肽酶80抑制剂的鉴定
J Chem Inf Model. 2025 Mar 10;65(5):2636-2649. doi: 10.1021/acs.jcim.4c02152. Epub 2025 Feb 26.
7
Mitochondrial DNA Structure in .线粒体DNA结构于……中 (原文不完整,翻译可能不太准确,需结合完整原文进一步完善)
Pathogens. 2025 Jan 14;14(1):73. doi: 10.3390/pathogens14010073.
8
Factors influencing the use of direct oral anticoagulants among patients with chronic chagas cardiomyopathy.影响慢性恰加斯心肌病患者使用直接口服抗凝剂的因素。
Arch Peru Cardiol Cir Cardiovasc. 2024 Dec 11;5(4):198-206. doi: 10.47487/apcyccv.v5i4.433.. eCollection 2024 Oct-Dec.
9
Early assessment of antibodies decline in Chagas patients following treatment using a serological multiplex immunoassay.使用血清学多重免疫测定法对恰加斯病患者治疗后抗体下降情况进行早期评估。
Nat Commun. 2024 Dec 3;15(1):10530. doi: 10.1038/s41467-024-54910-x.
10
Recombinant proteins as promising antigens applied to the immunodiagnosis of Chagas disease: a scoping review.重组蛋白作为用于恰加斯病免疫诊断的有前景的抗原:一项范围综述
Front Microbiol. 2024 Jul 30;15:1420226. doi: 10.3389/fmicb.2024.1420226. eCollection 2024.